Skip to navigation Skip to content



About this Medication
  • Brand Name: Lemtrada™
  • Chemical Name: alemtuzumab
  • Usage in MS: Disease-Modifying Agent
  • Generic Available: No

This medication is given by IV infusion.


Lemtrada™ is a humanized monoclonal antibody directed at CD52 (a protein on the surface 
of immune cells).  
Lemtrada is approved by the FDA for the treatment of patients with relapsing forms of 
MS.  Because of Lemtrada’s safety profile, the FDA recommends that this medication
generally be reserved for people who have had an inadequate response to two or more MS
Click here to read the Lemtrada Prescribing Information for healthcare professionals.
Click here to read the Lemtrada Medication Guide for patients.


Call Genzyme at 1- 855-MSOne2One (1-855-676-6326)

Financial Assistance Program

Company: Genzyme

Usage in MS: Disease-Modifying Agent

MS One to One

1- 855-MSOne2One (1-855-676-6326)

Additional Resource

National Infusion Center Association - non-profit patient advocacy organization which offers an online Infusion Center Finder to locate centers throughout the U.S. 


What You Need To Know About Lemtrada™

This video was created in May, 2015 and features Gabriel Pardo, MD and Kathleen Costello, MSCN. Information is accurate as of then. To learn more about Lemtrada™ and other disease modifying treatment options, download the Consensus on Disease-Modifying Therapies and summary.

Watch Now